S. 2121: SUPPORT for Patients and Communities Reauthorization Act of 2025
A Senate bill (S.) in the 119th U.S. Congress.
Overview
| Congress | 119th U.S. Congress (2025–2026) |
|---|---|
| Type | Senate bill (S.) |
| Originating chamber | Senate |
| Introduced | 2025-06-18 |
| Sponsor | Sen. Cassidy, Bill [R-LA] |
| Policy area | Health |
| Cosponsors | 8 |
| Latest action | 2025-06-18 — Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
| Last updated | 2026-06-23 |
Summary
Official summary (Introduced in Senate, 2025-06-18):
SUPPORT for Patients and Communities Reauthorization Act of 2025
This bill reauthorizes and revises Department of Health and Human Services (HHS) programs that address substance use disorders, overdoses, and mental health.
For example, the bill reauthorizes for FY2026-FY2030 grant and other programs relating to
• addressing substance use disorders with respect to pregnant and postpartum women,
• prevention and recovery from substance use disorders for youth,
• housing for individuals in recovery from substance use disorders,
• community organizations facilitating recovery from substance use disorders,
• loan repayment for certain health care providers treating substance use disorders,
• prevention of overdoses of controlled substances,
• treatment of children experiencing psychological trauma, and
• mental and behavioral health education and training for medical and allied health students.
Also, the bill revises several programs, including by (1) expanding a program that supports resources for first responders to include the purchase of drugs or devices to treat non-opioid overdoses, (2) expanding a program that supports employment services for individuals in recovery so as to allow for the provision of related transportation services, and (3) temporarily authorizing a regional technical assistance center to assist the National Peer-Run Training and Technical Assistance Center for Addiction Recovery Support.
Additionally, the bill establishes new requirements for HHS, including requirements relating to
• protecting the National Suicide Prevention Lifeline program from cybersecurity threats,
• establishing a Federal Interagency Work Group on Fentanyl Contamination of Illegal Drugs, and
• reviewing and potentially revising the scheduling of approved products containing a combination of buprenorphine and naloxone under the Controlled Substances Act.
Cosponsors (8)
| Name | Party / state |
|---|---|
| Bernard Sanders | I VT (original cosponsor) 2025-06-18 |
| Lisa Murkowski | R AK (original cosponsor) 2025-06-18 |
| Tammy Baldwin | D WI (original cosponsor) 2025-06-18 |
| Sen. Mullin, Markwayne [R-OK] | R OK (original cosponsor) 2025-06-18 |
| Margaret Wood Hassan | D NH (original cosponsor) 2025-06-18 |
| Tommy Tuberville | R AL (original cosponsor) 2025-06-18 |
| John W. Hickenlooper | D CO (original cosponsor) 2025-06-18 |
| Jon Husted | R OH 2025-07-16 |
Full text & official record
The official bill text, section-by-section summary, amendments, committee reports, and the complete legislative timeline for S. 2121 are published by Congress on congress.gov.
View S. 2121 on congress.gov →
Frequently asked questions
What is S. 2121?
S. 2121 is a Senate bill (S.) introduced in the 119th U.S. Congress, originating in the Senate. Official title: SUPPORT for Patients and Communities Reauthorization Act of 2025.
Where can I read the full bill text?
The full text, cosponsors, amendments, and legislative status for S. 2121 are available on congress.gov.
Bill data: congress.gov API (official congressional records).